Heterocyclic compound, organic light-emitting element comprising same, and composition for organic material layer
US-2024298525-A1 · Sep 5, 2024 · US
Substituted quinoxalines and uses thereof
US8993758B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993758-B2 |
| Application number | US-201113883026-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 22, 2011 |
| Priority date | Nov 22, 2010 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are compounds of formula (I) and methods of inhibiting IKKβ and the NF-κB signaling and mTOR pathways.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound having a structure of formula (I) wherein each R 1 is independently heteroaryl, aryl, or alkyl; L is selected from —NHC(O)NH—, —NHC(O)CH 2 —, X is halo, alkyl, alkoxy, aryl, CO 2 alkyl, COalkyl, or haloalkyl;…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993758B2 cover?
- Disclosed herein are compounds of formula (I) and methods of inhibiting IKKβ and the NF-κB signaling and mTOR pathways.
- Who is the assignee on this patent?
- Natarajan Amarnath, Chen Qianyi, Bryant Vashti C, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C07D409/14. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).